Review of clinical evidence - Is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)?

Michael Shechter; Elieser Kaplinsky; Babeth Rabinowitz

doi:10.1097/00019501-199605000-00004

Review of clinical evidence - Is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)?

Michael Shechter^*, Elieser Kaplinsky, Babeth Rabinowitz

^*Corresponding author for this work

Cedars-Sinai Medical Center

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Original language	English
Pages (from-to)	352-358
Number of pages	7
Journal	Coronary Artery Disease
Volume	7
Issue number	5
DOIs	https://doi.org/10.1097/00019501-199605000-00004
State	Published - 1996

Keywords

clinical trials
coronary artery disease
magnesium
myocardial infarction

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00019501-199605000-00004

Cite this

@article{49798d5911494eaeb0488c2f966f8fe4,

title = "Review of clinical evidence - Is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)?",

keywords = "clinical trials, coronary artery disease, magnesium, myocardial infarction",

author = "Michael Shechter and Elieser Kaplinsky and Babeth Rabinowitz",

year = "1996",

doi = "10.1097/00019501-199605000-00004",

language = "אנגלית",

volume = "7",

pages = "352--358",

journal = "Coronary Artery Disease",

issn = "0954-6928",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "5",